INTERNATIONAL PATENT: ARNATAR THERAPEUTICS, INC FILES APPLICATION FOR "TRANSLATION ENHANCING NUCLEIC ACID COMPOUNDS: ASO COUPLED TRANSLATION - UPREGULATION 1 (ACT-UP1) AND USES THEREOF"

GENEVA, Aug. 12 -- ARNATAR THERAPEUTICS, INC (10355 Science Center Drive, Suite 130San Diego, CA 92121) filed a patent application (PCT/US2025/013612) for "TRANSLATION ENHANCING NUCLEIC ACID COMPOUNDS: ASO COUPLED TRANSLATION - UPREGULATION 1 (ACT-UP1) AND USES THEREOF" on Jan 29, 2025. With publication no. WO/2025/165891, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIANG, Xuehai (Arnatar Therapeutics, Inc10355 Science Center Drive, Suite 130San Diego, CA 92121), ZHANG, Lingdi (Arnatar Therapeutics, Inc10355 Science C...